The Beneficial Effect on the Bowel Function of a Food Supplement Based on Sea Buckthorn (Hippophae Rhamnoides L.) Extract in Subjects With Primary Functional Constipation
In plain words A study of sea Buckthorn in people 18 to 70, run by ISTITUTO FARMOCHIMICO FITOTERAPICO: EPO SRL. It plans to enroll about 135 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 to 70. Conditions: Functional Constipation (FC).
- aged between 18 and 70 years
- able to understand and sign informed consent
- HIV negative test
- negative pregnancy test
9 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Sea Buckthorn (Hippophae rhamnoides L.) botanical extract 500 mg.; Sea buckthorn (Hippophae rhamnoides L.) 1500 mg.; Placebo
Registered summary
The study will aim to evaluate the efficacy and tolerability of a supplementation with Sea Buckthorn (Hippophae rhamnoides L.) at two different dosages for the management of the balance of intestinal function in subjects with primary functional constipation. The full summary is on the listing.
Where, as registered
No US site; Italy (1).